Get started
Author

Roopesh R. Kansara

Observed names: R. Kansara, R.R. Kansara, Roopesh Kansara
Observed institutions: BC Cancer Agency, CancerCare Manitoba, Asklepios Klinik St. Georg, Asklepios, University of Manitoba, Saarland University, Leipzig University
OpenAlex ID: A5081906076
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
2016 · Norbert Schmitz, Samira Zeynalova, et al. · Journal of Clinical Oncology · 455
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
2016 · Kerry J. Savage, Graham W. Slack, et al. · Blood · 189
PDF
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma
2018 · Tarec Christoffer El-Galaly, Chan Yoon Cheah, et al. · European Journal of Cancer · 136
Rituximab with high‐dose methotrexate in primary central nervous system lymphoma
2015 · Roopesh Kansara, Tamara N. Shenkier, et al. · American Journal of Hematology · 49
PDF
Site of central nervous system (CNS) relapse in patients with diffuse large B‐cell lymphoma (DLBCL) by the CNS‐IPI risk model
2016 · Roopesh Kansara, Diego Villa, et al. · British Journal of Haematology · 33
PDF
Immunotherapy in Hematologic Malignancies
2020 · R.R. Kansara, C. Speziali · Current Oncology · 32
PDF
Validation of a Prognostic Model to Assess the Risk of CNS Disease in Patients with Aggressive B-Cell Lymphoma
2014 · Kerry J. Savage, Samira Zeynalova, et al. · Blood · 32
Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance
2019 · Joshua W. D. Tobin, Gabrielle Rule, et al. · Blood Advances · 27
Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder
2020 · Michael D. Jain, Ryan Lam, et al. · British Journal of Haematology · 19
Central Nervous System Prophylaxis Strategies in Diffuse Large B Cell Lymphoma
2018 · Roopesh Kansara · Current Treatment Options in Oncology · 18
Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas
2016 · R. Kansara, J. M. Connors, et al. · Haematologica · 13
The Impact of Concurrent MYC BCL2 Protein Expression on the Risk of Secondary Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma (DLBCL)
2014 · Kerry J. Savage, Laurie H. Sehn, et al. · Blood · 10
Outcome in Unselected Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Following R-CHOP When Stem Cell Transplantation Is Not Feasible
2014 · Roopesh R. Kansara, Kerry J. Savage, et al. · Blood · 9
The problem with cyclophosphamide, doxorubicin, vincristine and prednisone for the treatment of peripheral T-cell lymphoma
2013 · Roopesh Kansara, Kerry J. Savage · Leukemia & lymphoma/Leukemia and lymphoma · 9
PDF
Is primary prophylaxis with granulocyte colony stimulating factor (G-CSF) indicated in the treatment of lymphoma?
2013 · Roopesh Kansara, Rajat Kumar, et al. · Transfusion and Apheresis Science · 7
Outcomes of Stage I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance
2018 · Joshua W.D. Tobin, Gabrielle Rule, et al. · Blood · 3
Diffuse large B‐cell lymphoma mimicking cardiac amyloidosis
2017 · Lawrence Lau, Viktoriya Mozolevska, et al. · Clinical Case Reports · 2
PDF
An International Collaborative Study of Outcome and Prognostic Factors in Patients with Secondary CNS Involvement By Diffuse Large B-Cell Lymphoma
2016 · Tarec Christoffer El-Galaly, Chan Yoon Cheah, et al. · Blood · 2
Real-World Outcome of Dose-Adjusted EPOCH-R, a Single-Centre Experience
2020 · Rachel Wong, Roopesh R. Kansara · Blood · 1
The Absolute Number of Extranodal Sites Detected By PET-CT Is a Powerful Predictor of Secondary Central Nervous System Involvement in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP
2015 · Chan Yoon Cheah, Martin Hutchings, et al. · Blood · 1
Rituximab with High Dose Methotrexate in the Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma
2014 · Roopesh R. Kansara, Tamara Shenkier, et al. · Blood · 1
Acute heparin-induced thrombocytopenia following aortic dissection repair with platelet count recovery and anti-platelet factor 4/heparin antibody seroreversion despite ongoing device-related heparin exposure
2026 · Anna R. Blankstein, Kaitlin P. Quinlan, et al. · Haematologica
PDF
Real-world safety and tolerability of rapid infusion obinutuzumab in chronic lymphocytic leukemia, small lymphocytic lymphoma and non-Hodgkin lymphoma: a provincial review
2025 · Harshal Senthil, Scott Streilein, et al. · Haematologica
PDF
Updates in the treatment of mantle cell lymphoma: A Canadian expert framework
2022 · Diego Villa, Roopesh Kansara, et al. · Canadian Hematology Today
PDF
Real-World Treatment Outcomes and Toxicities of Outpatient R-CHOP/R-DHAP in Patients with Mantle Cell Lymphoma Eligible for Autologous Stem Cell Transplant
2022 · Jiayu Yang, Pamela Skrabek, et al. · Blood
Works count: 29
Citation count: 1,047
H-index: 11
I10-index: 12
Year
Topic
Type